Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 5, 1998, Pages 721-727

  Redecke, Vanessa ^a   Dalhoff, Klaus ^a   Bohnet, Sabine ^a   Braun, Jörg ^a   Maass, Matthias ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA; CHLAMYDIAE; CHLAMYDOPHILA PNEUMONIAE;

HEPARIN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN DERIVATIVE; POLYMYXIN B; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL COUNT; CHEMOLUMINESCENCE; CHLAMYDOPHILA PNEUMONIAE; DRUG EFFECT; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MALE; METABOLISM; MICROBIOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; SECRETION;

ADULT; CELL COUNT; CHEMILUMINESCENT MEASUREMENTS; CHLAMYDOPHILA PNEUMONIAE; HEPARIN; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INFECTION; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKINS; MACROPHAGES, ALVEOLAR; MALE; PHAGOCYTOSIS; POLYMYXIN B; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032209747     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.5.3072     Document Type: Article

References (31)

1. Grayston, T. J., L. A. Campbell, C. C. Kuo, C. H. Mordhorst, P. Saikku, D. H. Thom, and S. P. Wang. 1989. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J. Infect. Dis. 161:618-625.
2. Dalhoff, K., and M. Maass. 1996. Chlamydia pneumoniae pneumonia in hospitalized patients. Chest 110:351-356.
3. Hahn, D. L., R. W. Dodge, and R. Golubjatnikov. 1991. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. J.A.M.A. 266:225-230.
4. Saikku, P., M. Leinonen, L. Tenkanen, E. Linnanmäki, M. R. Ekman, V. Manninen, M. Mänttäri, H. Frick, and J. K. Huttunen. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann. Intern. Med. 116:273-278.
5. Gran, J. T., R. Hjetland, and A. H. Andreassen. 1993. Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae. Scand. J. Rheumatol. 22:43-44.
6. Gaydos, C. A., J. T. Summersgill, N. N. Sahney, J. A. Ramirez, and T. C. Quinn. 1996. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells and arortic smooth muscle cells. Infect. Immun. 64:1614-1620.
7. Nakajo, M. M., P. M. Roblin, and M. R. Hammerschlag. 1990. Interaction of Chlamydia trachomatis with human alveolar macrophages. In Chlamydial Infections. W. R. Bowie, editor. Cambridge University Press, Cambridge. 28-31.
8. Robinson, P., D. Wakefield, D. M. Graham, J. F. Easter, and R. Penny. 1985. The chemiluminescence response of normal human leukocytes to Chlamydia trachomatis. Diagn. Immunol. 3:119-125.
9. Zvillich, M., and I. Sarov. 1985. Interaction between human polymorphonuclear leukocytes and Chlamydia trachomatis elementary bodies: electron microscopy and chemiluminescent response. J. Gen. Microbiol. 131:2627-2635.
10. Yong, E. C., S. J. Klebanoff, and C. C. Kuo. 1982. Toxic effect of human polymorphonuclear leukocytes on Chlamydia trachomatis. Infect. Immun. 37:422-426.
11. Holtmann, H., Y. Shemer-Avni, K. Wessel, I. Sarov, and D. Wallach. 1990. Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis. Infect. Immun. 58: 3168-3172.
12. Sarov, I., E. Geron, Y. Shemer-Avni, E. Manor, M. Zvillich, D. Wallach, E. Schmitz, and H. Holtmann. 1991. Implications for persistent chlamydial infections of phagocyte-microorganism interplay. Eur. J. Microbiol. Infect. Dis. 10:119-123.
13. Maass, M., and U. Harig. 1995. Evaluation of culture conditions used for isolation of Chlamydia pneumoniae. Am. J. Clin. Pathol. 103:141-148.
14. Miyashita, N., and A. Matsumoto. 1992. Establishment of a particle-counting method for purified elementary bodies of chlamydiae and evaluation of sensitivities of the IDEIA chlamydia kit and DNA probe by using the purified elementary bodies. J. Clin. Microbiol. 30:2911-2916.
15. Dalhoff, K., J. Braun, H. Kothe, M. Körber, M. Pein, and K. J. Wiessmann. 1994. Oxidative metabolism of pulmonary phagocytes in acute pneumonia. Respiration 61:144-149.
16. Feist, W., A. J. Ulmer, J. Musehold, H. Brade, S. Kusumoto, and H. D. Flad. 1989. Induction of tumor necrosis factor α release by lipopolysaccharides and defined lipopolysaccharide partial structures. Immunobiology 179:293-307.
17. Kamp, S., U. Kötschau, J. Braun, and K. Dalhoff. 1997. IL-8 in the context of phagocyte activation in community acquired pneumonia. Infection 25:95-100.
18. Kamp, S., B. Kreft, J. Braun, and K. Dalhoff. 1994. A rapid semiautomatic enzyme-linked immunoassay identifying intercellular adhesion molecule-1 (ICAM-1). Eur. J. Clin. Chem. Clin. Biochem. 32:455-460.
19. Byrne, G. I., J. M. Carlin, T. P. Merkert, and D. L. Ater. 1989. Long-term effects of gamma interferon on Chlamydia-infected host cells: microbicidal activity follows microbiostasis. Infect. Immun. 57:1318-1320.
20. La Verda, D., and G. I. Byrne. 1994. Interactions between macrophages and Chlamydiae. Immunol. Ser. 60:381-399.
21. Hammerschlag, M., K. Suntharalingam, and S. Fikrig. 1985. The effect of Chlamydia trachomatis on luminol-dependent chemiluminescence of human polymorphonuclear leukocytes: requirements for opsonization. J. Infect. Dis. 151:1045-1051.
22. Murray, H. W., G. I. Byrne, C. D. Rothermel, and D. M. Cartelli. 1983. Lymphokine enhances oxygen-independent activity against intracellular pathogens. J. Exp. Med. 158:234-239.
23. Heinemann, M., M. Susa, U. Simnacher, R. Marre, and A. Essig. 1996. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD 14 in human monocytic cell line. Infect. Immun. 64:4872-4875.
24. Yang, Z. P., P. K. Cummings, D. L. Patton, and C. C. Kuo. 1994. Ultrastructural lung pathology of experimental Chlamydia pneumoniae infection of the lung. J. Infect. Dis. 170:464-467.
25. Beatty, W. L., G. I. Byrne, and R. P. Morrison. 1994. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol. 2:94-98.
26. Shemer-Avni, Y., D. Wallach, and I. Sarov. 1988. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect. Immun. 56:2503-2506.
27. Ramirez, J. A. 1996. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: The Chlamydia/Atherosclerosis Study Group. Ann. Intern. Med. 125:979-982.
28. Byrne, G. I. 1976. Requirements for ingestion of Chlamydia psittaci by L cells. Infect. Immun. 14:645-651.
29. Zhang, J. P., and R. S. Stephens. 1992. Mechanisms of attachment of Chlamydia trachomatis to eukaryotic host cells. Cell 69:861-869.
30. Ingalls, R. R., P. A. Rice, N. Qureshi, K. Takayama, J. S. Lin, and D. T. Golenbock. 1995. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect. Immun. 63:3125-3130.
31. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818.